Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases.
Cellective Therapeutics is a biopharmaceutical company that engages in B Cell research for cancer and autoimmune diseases. Cellective focuses on monoclonal antibodies, which, with the company's technology, can be developed so specifically that they block the root causes of autoimmunity without interfering with the body's normal response to infections.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 29, 2004 | Series A | $27.50M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
BA Venture Partners | — | Series A |